These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15249184)

  • 1. Defective glycosylation of calsequestrin in heart failure.
    Kiarash A; Kelly CE; Phinney BS; Valdivia HH; Abrams J; Cala SE
    Cardiovasc Res; 2004 Aug; 63(2):264-72. PubMed ID: 15249184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered calsequestrin glycan processing is common to diverse models of canine heart failure.
    Jacob S; Sleiman NH; Kern S; Jones LR; Sala-Mercado JA; McFarland TP; Sabbah HH; Cala SE
    Mol Cell Biochem; 2013 May; 377(1-2):11-21. PubMed ID: 23456435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry of cardiac calsequestrin characterizes microheterogeneity unique to heart and indicative of complex intracellular transit.
    O'Brian JJ; Ram ML; Kiarash A; Cala SE
    J Biol Chem; 2002 Oct; 277(40):37154-60. PubMed ID: 12147690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation and dephosphorylation of calsequestrin on CK2-sensitive sites in heart.
    Ram ML; Kiarash A; Marsh JD; Cala SE
    Mol Cell Biochem; 2004 Nov; 266(1-2):209-17. PubMed ID: 15646044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different endoplasmic reticulum trafficking and processing pathways for calsequestrin (CSQ) and epitope-tagged CSQ.
    Houle TD; Ram ML; McMurray WJ; Cala SE
    Exp Cell Res; 2006 Dec; 312(20):4150-61. PubMed ID: 17045261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure.
    Takahashi T; Allen PD; Lacro RV; Marks AR; Dennis AR; Schoen FJ; Grossman W; Marsh JD; Izumo S
    J Clin Invest; 1992 Sep; 90(3):927-35. PubMed ID: 1326001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced sarcoplasmic reticulum Ca(2+)-uptake and expression of phospholamban in left ventricular myocardium of dogs with heart failure.
    Gupta RC; Mishra S; Mishima T; Goldstein S; Sabbah HN
    J Mol Cell Cardiol; 1999 Jul; 31(7):1381-9. PubMed ID: 10403755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural alterations in cardiac calcium release units resulting from overexpression of junctin.
    Zhang L; Franzini-Armstrong C; Ramesh V; Jones LR
    J Mol Cell Cardiol; 2001 Feb; 33(2):233-47. PubMed ID: 11162129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calsequestrin isoforms localize to different ER subcompartments: evidence for polymer and heteropolymer-dependent localization.
    Milstein ML; Houle TD; Cala SE
    Exp Cell Res; 2009 Feb; 315(3):523-34. PubMed ID: 19059396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficient glycosylation leads to high steady-state levels of actively degrading cardiac triadin-1.
    Milstein ML; McFarland TP; Marsh JD; Cala SE
    J Biol Chem; 2008 Jan; 283(4):1929-35. PubMed ID: 18025088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of drugs with muscle-related side effects and affinity for calsequestrin on the calcium regulatory function of sarcoplasmic reticulum microsomes.
    Kim E; Tam M; Siems WF; Kang C
    Mol Pharmacol; 2005 Dec; 68(6):1708-15. PubMed ID: 16141311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calsequestrin and the calcium release channel of skeletal and cardiac muscle.
    Beard NA; Laver DR; Dulhunty AF
    Prog Biophys Mol Biol; 2004 May; 85(1):33-69. PubMed ID: 15050380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure.
    Yeh YH; Wakili R; Qi XY; Chartier D; Boknik P; Kääb S; Ravens U; Coutu P; Dobrev D; Nattel S
    Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):93-102. PubMed ID: 19808399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Post-Translational Modifications to Calsequestrins of Cardiac and Skeletal Muscle.
    Lewis KM; Munske GR; Byrd SS; Kang J; Cho HJ; Ríos E; Kang C
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the presence of calsequestrin in two structurally different regions of myocardial sarcoplasmic reticulum.
    Jorgensen AO; Campbell KP
    J Cell Biol; 1984 Apr; 98(4):1597-602. PubMed ID: 6371026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.
    Ren B; Shao Q; Ganguly PK; Tappia PS; Takeda N; Dhalla NS
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1118-27. PubMed ID: 15644955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.
    Dash R; Frank KF; Carr AN; Moravec CS; Kranias EG
    J Mol Cell Cardiol; 2001 Jul; 33(7):1345-53. PubMed ID: 11437540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the editor: Re-evaluation of heart failure in transgenic mice with impaired SR Ca2+ release.
    Sato Y; Schmidt AG; Kiriazis H; Hoit BD; Kranias EG
    J Mol Cell Cardiol; 2001 Sep; 33(9):1757-9. PubMed ID: 11549354
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of calsequestrin in atrial and ventricular muscle of thermally acclimated rainbow trout.
    Korajoki H; Vornanen M
    J Exp Biol; 2009 Nov; 212(Pt 21):3403-14. PubMed ID: 19837881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calsequestrin: more than 'only' a luminal Ca2+ buffer inside the sarcoplasmic reticulum.
    Szegedi C; Sárközi S; Herzog A; Jóna I; Varsányi M
    Biochem J; 1999 Jan; 337 ( Pt 1)(Pt 1):19-22. PubMed ID: 9854019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.